⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
PFE
SNY
TSEM
JNJ
LLY
MRK
BMY
ABBV
GILD
CRSP
NKTR
INCY
Breast Cancer Drugs Market to Reach USD 57.1 Billion by 2031 as Precision Oncology and Targeted Therapies Redefine Treatment Outcomes
prnewswire.com
NVS
LLY
AZN
MRK
ABBV
BMED
MGNX
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
globenewswire.com
ABBV
BMY
GILD
AMGN
AZN
LLY
BIIB
REGN
VRTX
XBI
IBB
CRSP
EDIT
NTLA
ABCL
NVS
MRK
PFE
JNJ
GSK
SNY
BTAI
INSM
KEYTRUDA ® (pembrolizumab) Plus Padcev ® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
businesswire.com
MRK
Chemical Synthesis Peptide Drugs Market Set to Reach USD 4.82 Billion by 2034, Growing at a 6.54% CAGR Driven by Automation and Green Chemistry Advances
globenewswire.com
LLY
NVS
MRK
Advancium Health Network Names Michele Cleary CEO to Drive Next Phase of Pediatric Healthcare Innovation
prnewswire.com
BMY
MRK
Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer
globenewswire.com
NKTR
AMGN
MRK
INGN
ILMN
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
globenewswire.com
ADAG
MRK
Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity
businesswire.com
MRK
Insomnia Drugs Market Outlook 2026-2034: Trends, Shares, and Growth Analysis Featuring Merck & Co., Eisai Co., Viatris, Perrigo Co., Neurim Pharmaceuticals and More - ResearchAndMarkets.com
businesswire.com
MRK
VTRS